Amara Raja Energy and Mobility: Strong Q1 FY27 Growth, But Margins Show the Cost of Transition

Amara Raja Energy & Mobility Limited reported a sharp jump in topline in Q1 FY27, even as profitability moderated under the weight of raw material inflation and higher strategic spending. On a consolidated basis, revenue from operations rose to INR 4,215 crore, up 23.9 percent year on year. EBITDA increased 11.7 percent to INR 406 crore, but EBITDA margin slipped to 9.6 percent from 10.7 percent a year ago. PAT grew 15.8 percent to INR 191 crore, with PAT margin at 4.5 percent.

The quarter captured the company in the middle of two realities. The core lead-acid franchise delivered healthy growth in domestic OEM and aftermarket channels. At the same time, the company leaned into its transition agenda, funding brand investments and new initiatives such as Amaron Assist and manufacturing excellence programs, while continuing to build its new energy manufacturing corridor through its wholly owned subsidiary, Amara Raja Advanced Cell Technologies.

A quarter led by lead-acid, with new energy gaining pace

The revenue mix remains heavily skewed toward lead-acid batteries. In Q1 FY27, the lead-acid business contributed 95 percent of revenue, at INR 4,005 crore. Other businesses contributed 5 percent, at INR 209 crore. Within that smaller pool, management said the new energy business grew more than 70 percent year on year, driven by higher demand for telecom packs and EV packs.

Demand commentary for the lead-acid business was largely constructive on the domestic side. Management cited sustained volume momentum in both aftermarket and OEM segments, including around 15 percent growth in four-wheeler and two-wheeler aftermarket volumes. OEM volumes were cited as particularly strong, with around 24 percent growth in four-wheelers and more than 35 percent in two-wheelers. The home energy business also saw strong growth, with management stating more than 60 percent growth in tubular batteries and home EPS during the quarter.

Industrial performance was mixed. UPS batteries recorded around 10 percent volume growth, supported by demand from data centres. Telecom lead-acid batteries continued to decline, reflecting the sector’s migration toward lithium-ion solutions.

Exports were the soft spot. The investor presentation showed export share falling to 7 percent of Q1 FY27 revenue from 11 percent in Q1 FY26 and Q4 FY26. Management attributed the weakness to geopolitical factors and higher freight costs, noting around 20 percent volume degrowth in automotive exports, particularly in the Middle East.

Margin pressures: inflation, promotions, and strategic investments

The margin decline in Q1 FY27 was not positioned as a demand issue. Management attributed it to a combination of cost inflation and deliberate investments.

A key driver was raw material inflation. Management specifically called out a significant increase in procurement costs for alloy, sulfuric acid, and polymer. While some inflation had already started in Q4 FY26, management said sulfuric acid and polymer prices rose substantially during the quarter.

To counter this, the company took a price increase of around 3 percent in June. However, management acknowledged that the hike did not fully offset cost pressures. It also guided that an additional 2 percent to 3 percent price increase would be rolled out during the current month, indicating a continued effort to protect margins if input prices stabilize.

The second driver was higher spending on brand promotions and strategic initiatives. The company highlighted increased investment in brand presence, including IPL. It also reiterated spending on Amaron Assist, a doorstep service pilot, and on manufacturing excellence initiatives under the Factory of the Future theme. Management explained that some debottlenecking initiatives improve throughput but cannot be capitalized under accounting rules, leading to higher revenue expenditure.

Warranty provisioning was another factor. Management noted that higher raw material prices also increased warranty provisions because the provision must cover the cost of servicing the unexpired warranty population at higher input costs.

New energy buildout: timelines and capital allocation become central

While lead-acid continues to anchor revenue, the company’s strategic direction is increasingly defined by its new energy investments.

In July 2026, the company commissioned its Customer Qualification Plant, described as a multi-chemistry, multi-form factor pilot facility designed for pilot production and product optimization. Management positioned it as a dual-purpose asset: accelerating customer qualification and improving manufacturing readiness for the first giga cell plant by helping reduce ramp-up costs.

The E Positive facility, positioned as a research facility, is expected to commence operations in Q2 FY27, as per management commentary. The investor presentation described the E Positive lab as an under-construction R&D center with test and validation labs.

The largest near-term commercial effort is in battery energy storage systems. The investor presentation indicated that construction of the 10 GWh BESS giga factory has commenced, with operations expected to begin in Q3 FY27. On the earnings call, management provided early economics for the BESS business, stating an expected capex range of INR 250 crore to INR 300 crore for a 10 GWh line. It indicated operating margins could be around 7 percent to 8 percent, with a conservative possibility of 5 percent to 6 percent. Management also said it sees visibility with EPC players and believes utilization could reach around 5 GWh within about 6 to 7 months of factory completion, subject to market demand.

On lithium cells, the company reiterated its phased approach. The investor presentation described Phase 1 of the giga cell factory as 2 GWh based on NMC chemistry, expected to commence in Q2 CY2027, with a stated ambition to reach 16 GWh by FY30. Management added an important nuance: the capacity milestone can change based on demand signals and product mix, and the company does not intend to build capacity without clarity on cell demand.

Capex guidance reinforces this pivot. Management guided that FY27 capex is estimated at around INR 1,700 crore, of which around INR 1,300 crore is toward new energy. It also disclosed that around INR 450 crore was spent in Q1 FY27, primarily toward the new energy business. The upcoming Giga 1 plant was indicated as expected to commercialize during H1 FY28.

Recycling and compliance: early-stage execution, economics to watch

The investor presentation also highlighted a lead recycling plant at Cheyyar, positioned as part of the company’s circular economy push. It stated current refining capacity of 100,000 MT per annum, with eventual capacity of 150,000 MT per annum.

On the call, management clarified that battery breaking operations are still in trial production. It also flagged that scrap prices have moved substantially higher, making recycled lead economics less favorable in the near term. Management said the costs of buying scrap and reprocessing lead were almost equal to or slightly higher than LME lead during the quarter. It expects that once operations stabilize and its EPR-linked battery procurement feeds the plant, contribution to margins could improve, but it refrained from quantifying the benefit until the process stabilizes.

Separately, management disclosed a regulatory update: the Andhra Pradesh Pollution Control Board revoked a closure order issued in April 2021, and the company withdrew the related writ petition after the revocation on July 18, 2026.

Takeaways from Q1 FY27

Q1 FY27 highlighted the company’s ability to deliver robust topline growth while also showing the financial cost of executing a broader transition agenda. The lead-acid business continues to provide scale, brand strength, and cash generation potential, especially in domestic markets where OEM and aftermarket momentum remains strong.

But the quarter also underlined the near-term fragility of margins. Raw material inflation, higher warranty provisioning, and strategic expenditure on promotions and new initiatives compressed profitability despite price hikes.

The next few quarters are likely to be judged on two measurable outcomes. First, whether price increases and input cost normalization can restore operating margins. Second, whether the new energy capex program continues to hit commissioning timelines, especially with the E Positive facility expected in Q2 FY27 and BESS operations expected in Q3 FY27. The company’s disclosures provide a clearer operating calendar than in earlier phases of the transition, and that should help investors track execution with greater discipline.